Deleting miR-155 limits the proportion of activated T cells and the levels of inflammatory cytokines IFN-γ, IL-4 and IL-17 secreted by Th1, Th2, and Th17 cells, thus alleviating the disease severity of lupus-prone mice (108). This evidence concerns the gene IL17A and systemic lupus erythematosus.